- Joined
- 4 February 2006
- Posts
- 564
- Reactions
- 0
Its getting more difficult to find a stock that doesn't have a broker's strong buy recco on it scaffy but the market just doesn't hear it.
Its getting more difficult to find a stock that doesn't have a broker's strong buy recco on it scaffy but the market just doesn't hear it.
This stock has laid dormant for a while and has been spared the lashings of others at a similar stage, in the current environment. I think there are many holders just waiting for EMS to kick off. There is a general meeting in November, even with final trials for artimist and it being put on the market could this stock really take off in the next year??
Tucks it has laid low for some time and has not fallen to the depths of many stocks, they say that it should be able to get on market in 3rd quarter of 2009. A friend of mine is going to that meeting and hopefully get some more info. But we are all hoping it rockets up.
scaf
- Joined
- 24 June 2009
- Posts
- 1
- Reactions
- 0
hi all, first time poster and thought I'd drag up an old thread 
Im very new to the stock market and really dont know what Im doing tbh but thats my problem
Ive had shares in Eastland for well over a year now and have watched it remain stagnant for quite some time before I bought (as well as after) until the latest downward spiral in share price (as with most stocks) but Im curious to hear other peoples thoughts on this company. It appears that the final stages are finally in place and they are not far off producing and selling artimist if all goes well.
I dont have any specific questions, i really just wanted to re-open this thread for discussion in the hope that it would rekindle some interest.
Is this the beginning of a long awaited price rise??
Im very new to the stock market and really dont know what Im doing tbh but thats my problem
Ive had shares in Eastland for well over a year now and have watched it remain stagnant for quite some time before I bought (as well as after) until the latest downward spiral in share price (as with most stocks) but Im curious to hear other peoples thoughts on this company. It appears that the final stages are finally in place and they are not far off producing and selling artimist if all goes well.
I dont have any specific questions, i really just wanted to re-open this thread for discussion in the hope that it would rekindle some interest.
Is this the beginning of a long awaited price rise??
- Joined
- 17 June 2009
- Posts
- 2
- Reactions
- 0
Hey,
I held EMS back in the day - me and a mate had a bit of a gamble, there were 2 suppliers of single use syringes going for major contracts. One was EMS and the other I can't recall (prob around 2003ish).. Anyway, we flipped a coin, he bougth $5k in one company and I bought $5k in EMS.....
Needless to say, he got a ski trip to Canada with his profits. I held EMS for a few months and sold for basically exactly what I bougth it for.
I'm not a follower of EMS (only vaguely) and I'm not too good at the biodmed stuff (depiste having a science degree and lab background - go figure!), but here are some thoughts:
At some point a few years ago EMS was trading in about the 30c mark. Some broker reports from the time were predicting a rise to 80-90c - nothing ever happened.
EMS hit somewhere aroung 3c a few weeks back and bounced a little.
Some people are are again rating it as a buy with stage 3 trials underway (or soon to be). From what I understand stage 3 trials can be long and have a high degree of failure.
My thoughts are that its trading cheap, and has potential IF the trials go well it could be a winner.
I suggest you focus on the fundamentals of the trials, and maybe someone on here that knows more about EMS and the biotech world can give some insight into potential success etc.
AtM
Don't trust my opinion - I have a full time job for a reason.....
I held EMS back in the day - me and a mate had a bit of a gamble, there were 2 suppliers of single use syringes going for major contracts. One was EMS and the other I can't recall (prob around 2003ish).. Anyway, we flipped a coin, he bougth $5k in one company and I bought $5k in EMS.....
Needless to say, he got a ski trip to Canada with his profits. I held EMS for a few months and sold for basically exactly what I bougth it for.
I'm not a follower of EMS (only vaguely) and I'm not too good at the biodmed stuff (depiste having a science degree and lab background - go figure!), but here are some thoughts:
At some point a few years ago EMS was trading in about the 30c mark. Some broker reports from the time were predicting a rise to 80-90c - nothing ever happened.
EMS hit somewhere aroung 3c a few weeks back and bounced a little.
Some people are are again rating it as a buy with stage 3 trials underway (or soon to be). From what I understand stage 3 trials can be long and have a high degree of failure.
My thoughts are that its trading cheap, and has potential IF the trials go well it could be a winner.
I suggest you focus on the fundamentals of the trials, and maybe someone on here that knows more about EMS and the biotech world can give some insight into potential success etc.
AtM
Don't trust my opinion - I have a full time job for a reason.....
We have seen an intra-day high of 6.0c today with volumes picking up from meagre levels in the previous 4 months. No announcements other than that of the 19th Aug, however no major revelations there.....
Stock has not responded to recent market rally so wonder where buying pressure is coming from??
Any ideas anyone??
Stock has not responded to recent market rally so wonder where buying pressure is coming from??
Any ideas anyone??
Hello,
I bought into EMS at beginning of Oct at 0.074 on their way back up from the low of 0.03.. since then they have reached a high of 0.105 and sitting at around 0.080 now. Nice profit if you started at 0.03 I guess.
I was wondering if anyone can share any further info they may have on EMS? obviously I am hoping phase III trials for their Malaria product goes well.. the info EMS release to us investors seems minimal.. although it is my understainding that they cannot release too much in the way of how trials are going.
Anyway should be good if they pull it off... lets hope they do. Any info would be appreciated.
Regards
Chris
I bought into EMS at beginning of Oct at 0.074 on their way back up from the low of 0.03.. since then they have reached a high of 0.105 and sitting at around 0.080 now. Nice profit if you started at 0.03 I guess.
I was wondering if anyone can share any further info they may have on EMS? obviously I am hoping phase III trials for their Malaria product goes well.. the info EMS release to us investors seems minimal.. although it is my understainding that they cannot release too much in the way of how trials are going.
Anyway should be good if they pull it off... lets hope they do. Any info would be appreciated.
Regards
Chris
- Joined
- 3 May 2009
- Posts
- 515
- Reactions
- 2
This company popped up on my radar earlier in the week after it's little run up.
Took a closer look and decided to take a position.
Pattersons has a target price of 29 cents!
It's taken a long painful fall in sp as it moves towards registration of it's anti-malaria drug but now the stars are lining up!
Phase 2 clinical trials have been a success .....and now the clinical test results are going to be released at the 2010 Interscience Conference in a few weeks to a huge global audience of big pharma, ngo's governments and investors.
A quarter or two could see this struggling little biotech in a very different situation.
Just food for thought half the worlds population are at risk of malaria, every year 250 million people die of it including 20% of all childhood deaths in Africa. http://www.who.int/features/factfiles/malaria/en/index.html
airTmist is an effective easily administered oral spay ( especially for children)that can sit on a shelf for 2 years at 40C.
A great ethical investment with all the usual biotech risks and rewards if it suits your risk profile!
I'll be following this story for a while anyways
Took a closer look and decided to take a position.
Pattersons has a target price of 29 cents!
It's taken a long painful fall in sp as it moves towards registration of it's anti-malaria drug but now the stars are lining up!
Phase 2 clinical trials have been a success .....and now the clinical test results are going to be released at the 2010 Interscience Conference in a few weeks to a huge global audience of big pharma, ngo's governments and investors.
A quarter or two could see this struggling little biotech in a very different situation.
Just food for thought half the worlds population are at risk of malaria, every year 250 million people die of it including 20% of all childhood deaths in Africa. http://www.who.int/features/factfiles/malaria/en/index.html
airTmist is an effective easily administered oral spay ( especially for children)that can sit on a shelf for 2 years at 40C.
A great ethical investment with all the usual biotech risks and rewards if it suits your risk profile!
I'll be following this story for a while anyways
This company popped up on my radar earlier in the week after it's little run up.
Took a closer look and decided to take a position.
Pattersons has a target price of 29 cents!
It's taken a long painful fall in sp as it moves towards registration of it's anti-malaria drug but now the stars are lining up!
Phase 2 clinical trials have been a success .....and now the clinical test results are going to be released at the 2010 Interscience Conference in a few weeks to a huge global audience of big pharma, ngo's governments and investors.
A quarter or two could see this struggling little biotech in a very different situation.
Just food for thought half the worlds population are at risk of malaria, every year 250 million people die of it including 20% of all childhood deaths in Africa. http://www.who.int/features/factfiles/malaria/en/index.html
airTmist is an effective easily administered oral spay ( especially for children)that can sit on a shelf for 2 years at 40C.
A great ethical investment with all the usual biotech risks and rewards if it suits your risk profile!
I'll be following this story for a while anyways
Phase 3 field trial completed.
Management is confidentEastland’s Board is pleased to provide you with the following update from the African ART004 Clinical Trial titled,
“A Phase III, randomized, open labelled, active controlled, multi-centre, superiority trial of ArTiMist™ versus intravenous quinine in children with severe or complicated falciparum malaria, or uncomplicated falciparum malaria with gastrointestinal complications.”
We have received confirmation that the recruitment of patients for the trial is complete and the trial is now fully enrolled. We can also confirm that patient dosing has also been completed and that all patients have now completed their 28 day follow-up. This marks the completion of the field aspects of the clinical trial. This is a significant milestone in the development program for ArTiMist™.
The pharmacodynamics studies, biochemistry and parasitology and other evaluations of the patient data are now underway. These results will then be forwarded to the Biostatisticians for analysis and then to the Medical Writer for compilation into the final clinical report. It is anticipated that this should be completed during the 4th quarter of this year.
Not wanting to foreshadow the statistical scientific evidence of the trial results, Management remains confident that these confirmatory trials will support the conclusions of the Phase II trials that ArTiMist™ can provide a viable alternative to the commonly accepted treatment of intravenous quinine.
Eastland’s Board will provide a further update on the progress of the manufacturing program in the near future.
Interesting little spec. Getting closer to a result?
Anyone else on the forum interested with Eastern Medical?
If the final phase 3 of the Arti mist is approved by the end of the this year..... (management is fairly confident it will) How can one work out the true value of the stock based on selling the patient product of Artimist?
Patterson's had EMS valued at 29c a few years ago when Artimist around .07c. Unless they've had some CR in meantime you'd think that it would be at a higher sp of .035c... Especially now that it's completed it's final stage and looking at the end of the year for approval.
Cant understand why EMS and the product Artimist after all these years of nearing completion has no interest on the thread.
If the final phase 3 of the Arti mist is approved by the end of the this year..... (management is fairly confident it will) How can one work out the true value of the stock based on selling the patient product of Artimist?
Patterson's had EMS valued at 29c a few years ago when Artimist around .07c. Unless they've had some CR in meantime you'd think that it would be at a higher sp of .035c... Especially now that it's completed it's final stage and looking at the end of the year for approval.
Cant understand why EMS and the product Artimist after all these years of nearing completion has no interest on the thread.
I too am also wondering if anyone else here is interested.
IMO ems is looking good, being that todays anouncement that ems has been invited to present at 'Malaria 2012: Saving Lives in the Pacific'. this should provide good exposure for ems hopefully renewing interest.
im looking for to whats to come in the coming months
IMO ems is looking good, being that todays anouncement that ems has been invited to present at 'Malaria 2012: Saving Lives in the Pacific'. this should provide good exposure for ems hopefully renewing interest.
im looking for to whats to come in the coming months
SUD formerly EMS
It seems to be getting more attention of late.
Up 25% today with an increase in volume of 8mil which i guess at 4.5c doesn't equate to too much ($350,000) none the less where there's smoke there's fire.
With the name change how is it possible to line up the old EMS chart with the new SUD or cant it be done?
